Fieldwork dates: 6th-9th March 2020
Total sample size: 2065 adults
Conducted by: YouGov
On Behalf of: The Association for the Cannabinoid Industry
This survey data was collected and analysed by YouGov plc.
Please see the related press release : New Poll Finds Overwhelming Public Support For FSA CBD Regulation (11 March 2020)
Methodology
This survey has been conducted using an online interview administered to members of the YouGov Plc UK panel of 800,000+ individuals who have agreed to take part in surveys. Emails are sent to panellists selected at random from the base sample. The e-mail invites them to take part in a survey and provides a generic survey link. The responding sample is weighted to the profile of the sample definition to provide a representative reporting sample. The profile is normally derived from census data or, if not available from the census, from industry accepted data.
YouGov plc make every effort to provide representative information. All results are based on a sample and are therefore subject to statistical errors normally associated with sample-based information.
Questions and responses
CBD_Q1. For the following question, by “cannabidiol (CBD)”, we mean the oil extracted from a cannabis plant (also known as a marijuana plant). Before taking this survey, were you aware of any cannabidiol (CBD) based products?
- Yes, I was – 71%
- No, I wasn’t – 29%
CBD_Q1b. You previously mentioned you are aware of CBD cannabidiol (CBD) based products… Have you ever purchased any CBD cannabidiol (CBD) based products?
- Yes, I have – 16%
- No, I haven’t – 83%
- Don’t know/ can’t recall – 1%
CBD_Q2. You previously mentioned you are aware of CBD cannabidiol (CBD) based products… How confident, if at all, are you that all CBD products are labelled with the correct information and properly tested by a regulatory authority?
- Very confident – 6%
- Fairly confident – 24%
- Not very confident – 29%
- Not at all confident – 15%
- Don’t know – 26%
- Net: Confident – 29%
- Net: Not confident – 45%
CBD_Q3. How much more or less likely would you be to purchase/ use CBD cannabidiol (CBD) based products, if you could be certain that they had been produced to tight regulatory standards (i.e. they were rigorously tested and had to provide lots of information about the ingredients), or would it make no difference?
- Much more likely – 19%
- Slightly more likely – 27%
- No difference – 40%
- Slightly less likely – 1%
- Much less likely – 2%
- Don’t know – 11%
- Net: More likely – 46%
- Net: Less likely – 3%
CBD_Q4.
- The FSA (i.e. the Food Standards Agency) has reviewed the evidence on CBD cannabidiol (CBD) products and found evidence there are potential adverse health effects from the consumption.
- They have set a deadline of the 31st March 2021 for businesses that produce CBD cannabidiol (CBD) based products to provide more information about CBD products and their contents.
- They also advise vulnerable groups (e.g. pregnant women etc.) not to take CBD products, and healthy adults to take no more than 70mg a day.
Thinking about what you have just read:
How much do you support or oppose the FSA’s decision?
- Strongly support – 35%
- Tend to support – 39%
- Tend to oppose – 6%
- Strongly oppose – 2%
- Don’t know – 18%
- Net: Support – 74%
- Net: Oppose – 8%
Editor notes
All figures, unless otherwise stated, are from YouGov Plc. Total sample size was 2065 adults. Fieldwork was undertaken between 6th – 9th March 2020. The survey was carried out online. The figures have been weighted and are representative of all GB adults (aged 18+).
